Divi's Laboratories Limited reported earnings results for the third quarter and nine months ended December 31, 2025. For the third quarter, the company reported sales was INR 26,040 million compared to INR 23,190 million a year ago. Revenue was INR 26,920 million compared to INR 24,010 million a year ago. Net income was INR 5,830 million compared to INR 5,890 million a year ago. Basic earnings per share from continuing operations was INR 21.98 compared to INR 22.2 a year ago. Diluted earnings per share from continuing operations was INR 21.98 compared to INR 22.2 a year ago.
For the nine months, sales was INR 77,290 million compared to INR 67,750 million a year ago. Revenue was INR 80,810 million compared to INR 70,410 million a year ago. Net income was INR 18,170 million compared to INR 15,290 million a year ago. Basic earnings per share from continuing operations was INR 68.44 compared to INR 57.6 a year ago. Diluted earnings per share from continuing operations was INR 68.44 compared to INR 57.6 a year ago.
Divi's Laboratories Limited is specialized in the development and manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients.
Net sales by source of revenue break down into product sales (97.9%) and service sales (2.1%).
At the end of March 2020, the group has 2 production sites located in India.
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Choose MarketScreener 
